PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. akaryagina@gmail.com.\', \'All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.\', \'Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.\', \'Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.\', \'Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. subbotinam@gmail.com.\', \'Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, 197376, Russia.\', \'Saint Petersburg Institute of Vaccines and Sera, FMBA, St. Petersburg, 198320, Russia.\', \'Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1134/S0006297921100096
?:hasPublicationType
?:journal
  • Biochemistry. Biokhimiia
is ?:pmid of
?:pmid
?:pmid
  • 34903153
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all